Alzheimer's disease and blood-based biomarkers – potential contexts of use
Martina Zvěřová1,2 1Department of Psychiatry, General University Hospital in Prague, Prague, Czech Republic; 2First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Abstract: Alzheimer’s disease (AD) is an irreversible, incurable, progressive neurodege...
Saved in:
Main Author: | Zvěřová M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/a514407a084f4d9b82b3e2f59a195e91 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salivary Biomarkers in Alzheimer´s Disease
by: Santos,Gustavo A. A, et al.
Published: (2020) -
All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease
by: Yi-Yao Liang, et al.
Published: (2022) -
Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
by: Xin-Yu Yang, et al.
Published: (2021) -
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
by: Vyronia Vassilakopoulou, et al.
Published: (2021) -
APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018)